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1. Introduction 
Mechanical ventilation has become a standard technique to support the life of the critically 
ill patient in the intensive care unit (ICU) (Tobin, 2001). In general, mechanical ventilation is 
applied when the patient’s spontaneous ventilation is inadequate to maintain life. Especially 
patients who have developed acute respiratory failure require mechanical ventilation 
(Slutsky, 1993). Patients diagnosed with acute lung injury (ALI) suffer from severe 
pulmonary dysfunction which may persist for a long period of time. The extent and severity 
of ALI differs among patients, with the acute respiratory distress syndrome (ARDS) being 
the most severe manifestation of this lung disease (Schwarz, 2001). ALI and ARDS are 
characterized by the acute onset of diffuse neutrophilic alveolar infiltrates, protein-rich 
edema due to enhanced alveolar-capillary permeability and hypoxemic respiratory failure 
(ratio of arterial oxygen partial pressure to fractional inspired oxygen concentration, 
PaO2/FiO2 < 300 for ALI or < 200 for ARDS) (Ashbaugh et al, 1967; Petty & Ashbaugh, 
1971). These pulmonary disorders may result from local injuries like pneumonia, gastric 
aspiration, near-drowning and lung contusion, but also from systemic events like severe 
sepsis, shock and blood transfusions (Hudson et al, 1995; Ware & Matthay, 2000). 
Although mechanical ventilation is a life-saving procedure, it has the potential to cause 
damage in healthy lung tissue or aggravate damage in diseased lung tissue (Dreyfuss & 
Saumon, 1998; Slutsky, 1999). The pulmonary complications secondary to mechanical 
ventilation are frequently referred to as ventilator-associated lung injury (VALI) in the 
clinical setting and ventilator-induced lung injury (VILI) in the experimental setting. As this 
chapter will primarily focus on experimental findings, the term VILI will be used.  
2. Pathogenesis of ventilator-induced lung injury 
VILI is characterized by enhanced alveolar-capillary permeability, accumulation of protein-
rich lung edema, disturbed alveolar fibrin turnover, production of inflammatory mediators, 
and - ultimately - impaired gas exchange. Interestingly, these patterns of injury are very 
similar to those seen in ALI and ARDS (Tsuno et al, 1991).  
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Over the years, various experimental models have been used to gather further insights into 
the mechanism(s) that may underlie the pathogenesis of VILI. These in vitro and in vivo 
studies support the clinical observations that mechanical ventilation evokes stretch trauma 
due to cyclic opening and collapse and/or overdistention of alveoli (Dreyfuss et al, 1985; 
Webb & Tierney, 1974). Ventilator-induced cyclic opening and closing of alveoli results in 
depletion of surfactant and renders the lung more prone to collapse (Dreyfuss et al, 1988; 
Mead et al, 1970). Extensive research demonstrated that surfactant depletion initiates loss of 
alveolar-capillary barrier function (Lachmann et al, 1987; Seeger et al, 1993; Verbrugge et al, 
1997). In turn, serum proteins will leak from the circulation into pulmonary tissue. Protein 
accumulation in the lung will lead to surfactant inactivation, causing even more protein 
leakage and edema formation and eliciting a vicious circle of progressive lung injury 
(Ikegami et al, 1984; Lachmann et al, 1994). Besides surfactant dysfunction, other 
mechanisms have been proposed to be crucially involved in the development of VILI as 
well. It is reasonable to assume that these underlying mechanisms are interconnected. 
2.1 Inflammatory response 
Leukocyte-endothelial interactions have been described to be important in the pathogenesis of 
severe inflammatory diseases related to VILI, like ALI/ARDS (Abraham, 2003; Moraes et al, 
2003). In inflammation, pulmonary endothelial cells undergo a phenotypic shift (Orfanos et al, 
2004). Activated endothelial cells secrete chemotactic cytokines (chemokines) which are 
essential for the recruitment of leukocytes to the site of inflammation (Luscinskas & Gimbrone, 
Jr., 1996). The main pulmonary chemoattractant is interleukin (IL)-8 or its rodent equivalents 
macrophage inflammatory protein (MIP)-2 and keratinocyte-derived chemokine (KC) 
(Donnelly et al, 1993). Besides release of chemokines and other inflammatory mediators, 
activated endothelial cells express various adhesion molecules on their cell surface thereby 
directing the multi-step cascade of leukocyte transmigration from blood vessels into affected 
tissue (Luscinskas & Gimbrone, Jr., 1996). The initial step of transmigration involves members 
from the selectin family (P- and E-selectin) which tether circulating leukocytes to vascular 
endothelium and facilitate rolling of leukocytes along the blood vessel wall (Carlos & Harlan, 
1994). Subsequent leukocyte adhesion and extravasation are mediated by the immunoglobulin 
(Ig) superfamily comprising vascular cell adhesion molecule (VCAM)-1, intercellular adhesion 
molecule (ICAM)-1 and platelet-endothelial cell adhesion molecule (PECAM)-1. In ALI and 
ARDS patients, Gando et al. observed that soluble P-selectin, E-selectin, ICAM-1 and VCAM-1 
levels were elevated within 24 hours after diagnosis (Gando et al, 2004). In addition, these 
authors showed a marked increase in these soluble adhesion molecules when subdividing 
patients into survivors and non-survivors. Together, these findings imply that adhesion 
molecules may have a prognostic value for development and clinical outcome of inflammatory 
lung diseases (Gando et al, 2004). 
Activated leukocytes release oxygen-based free radicals and proteolytic enzymes to restore 
physiological conditions of inflamed tissue. However, activated leukocytes may obstruct 
micro-capillaries in the lung due to an increased cellular size leading to ischemia and 
augmented oxygen-based free radical production. Accumulation of these inflammatory cells 
in the alveoli may therefore cause severe disruption of pulmonary epithelial-endothelial 
barriers leading to impaired gas exchange (Abraham, 2003; Lee & Downey, 2001). 
Kawano et al. were the first to describe that granulocyte depletion prior to injurious 
mechanical ventilation ameliorates pulmonary dysfunction in a rodent model of surfactant 
deficiency, stressing the importance of inflammatory mediators in the pathogenesis of VILI 
(Kawano et al, 1987). Later, Tremblay et al. revealed that alveolar stretch imposed by ex vivo 
mechanical ventilation caused IL-1┚, tumor necrosis factor (TNF)-┙, IL-6, MIP-2, interferon 
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(IFN)-┛ and IL-10 expression and introduced the term “biotrauma” to describe the ventilator-
induced secretion of inflammatory mediators (Tremblay et al, 1997; Tremblay & Slutsky, 1998). 
In line with this concept, it has been shown that alveolar macrophages secrete cytokines and 
chemokines upon in vitro applied mechanical stretch (Pugin et al, 1998). Although alveolar 
macrophages are considered to be the most important source of pulmonary cytokines and 
chemokines, other cell types like fibroblasts, leukocytes, epithelial and endothelial cells are also 
capable of producing inflammatory mediators (Kelley, 1990). In this respect, in vitro studies 
clearly showed that alveolar epithelial and capillary endothelial cells indeed release cytokines 
and chemokines upon mechanical stretch (Iwaki et al, 2009; Vlahakis et al, 1999). Ranieri et al. 
were the first to provide clinical evidence for the biotrauma-hypothesis (Ranieri et al, 1999). In 
a randomized controlled trial, these authors observed elevated concentrations of IL-1β, TNF-α, 
IL-6 and IL-1 receptor antagonist in the bronchoalveolar lavage fluid (BALf) of ALI/ARDS 
patients when excessive tidal volumes were used for 36 hours (Ranieri et al, 1999).  
Based on experimental and clinical observations, it has been hypothesized that the 
ventilator-induced inflammatory response in the lung may lead to pulmonary injury 
(Haitsma et al, 2003; Wilson et al, 2003; Wilson et al, 2005). Most experimental models of 
VILI, however, applied excessively high tidal volumes and/or inspiratory pressures 
compared to those applied in the clinical setting (Copland et al, 2004; Haitsma et al, 2003; 
Wilson et al, 2003). In an attempt to better reflect the human situation, we used clinically 
more relevant ventilator settings in our animal studies (Hegeman et al, 2010). In this way, 
we were able to prevent shock, metabolic acidosis and substantial damage to lung 
architecture commonly associated with high tidal volumes and/or inspiratory pressures 
(Wolthuis et al, 2009b). However, even in our relatively mild model of VILI, mechanical 
ventilation with either low (LVT) or high tidal volumes (HVT) caused increased cytokine, 
chemokine and adhesion molecule expression compared to non-ventilated control (NVC) 
animals, which was accompanied by marked granulocyte infiltration (Hegeman et al, 
2011b). BALf neutrophil numbers and inflammatory mediator levels were even higher when 
comparing lungs of HVT-ventilated mice to lungs of LVT-ventilated mice (Hegeman et al, 
2011b). Since lower PaO2/FiO2 ratios were only observed after HVT-ventilation, it seems 
plausible that ventilator-induced lung inflammation ultimately impairs gas exchange. In this 
respect, investigators suggested that enhanced pro-inflammation due to mechanical 
ventilation makes the patient more susceptible to a “second hit” (Bregeon et al, 2002). 
Mechanical ventilation itself may be the “second hit” when ventilating critically ill patients 
suffering from pulmonary injuries like ALI/ARDS or systemic events like sepsis (Headley et 
al, 1997; Meduri et al, 1995; Slutsky & Tremblay, 1998).  
2.1.1 Local versus systemic inflammation 
An important clinical observation is that most ventilated critically ill patients do not 
succumb to acute respiratory failure but rather to progressive multiple organ failure (MOF) 
(Ferring & Vincent, 1997; Montgomery et al, 1985; Valta et al, 1999). A definition of MOF has 
been provided by John Marshall, who defined it as “the development of potentially 
reversible physiologic derangement involving two or more organ systems not involved in 
the disorder that resulted in ICU admission, and arising in the wake of a potentially life-
threatening physiologic insult” (Marshall, 2001). In a clinical study, comprising 3147 
patients from 198 ICUs in 24 European countries, Vincent et al. observed significant organ 
dysfunction in 71% of the ICU patients most of them being septic patients (Vincent et al, 
2006). Moreover, they found a positive correlation between the number of organ systems 
failing and ICU mortality stressing the importance of MOF in the clinical outcome of 
critically ill patients (Vincent et al, 2006).  
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Fig. 1. Mechanical ventilation induces endothelial activation and inflammation in 
pulmonary, hepatic and renal tissue. 
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Reprinted with permission of Critical Care (Hegeman et al, 2009). To investigate whether 
alveolar stretch may cause endothelial activation and inflammation in the lung and distal 
organs, healthy mice were mechanically ventilated for 1, 2 or 4 hours with high pressures 
(i.e. high level of alveolar stretch). Non-ventilated mice served as a reference group. 
Spontaneous breathing animals were placed in an oxygen saturated box for 4 hours (FiO2 of 
1.0, hyperoxia) to evaluate whether the high FiO2 associated with our ventilation strategy 
may contribute to changes in the immune response. A, E, I: In total lung, liver and kidney 
homogenates, respectively, mRNA expression of the adhesion molecule E-selectin was 
determined by real-time RT-PCR. B-C, F-G, J-K: In addition, mRNA expression of the pro-
inflammatory cytokine interleukin (IL)-1┚ and the chemokine keratinocyte-derived 
chemokine (KC) was determined. Levels were normalized for expression of internal 
controls, i.e. the average value of ┚-actin and glyceraldehyde 3-phosphate dehydrogenase 
(GAPdH). D, H, L: In total lung, liver and kidney homogenates, respectively, 
myeloperoxidase (MPO) activity was determined as a measure of granulocyte infiltration. 
Levels were normalized for total protein concentration. Data are depicted relative to NVC 
and expressed as mean ± SEM for n = 4-8 animals. * p<0.05, ** p<0.01, *** p<0.001 
(parameters were analyzed by one-way ANOVA with least significant difference (LSD) 
post-hoc test). NVC = non-ventilated controls; 1h, 2h, 4h = ventilated for either 1, 2 or 4 
hours; O2 = hyperoxia for 4 hours; MV = mechanical ventilation.  
There is convincing evidence that leukocyte-endothelial interactions are not only important 
in the pathogenesis of pulmonary disorders (Abraham, 2003; Moraes et al, 2003) but also in 
systemic events like sepsis and MOF (Whalen et al, 2000). It has been proposed that an 
elevation of adhesion molecule expression might contribute to tissue injury and ultimately 
to MOF by facilitating leukocyte activation and migration (Bone, 1991; Parrillo, 1993). In this 
regard, we examined whether alveolar stretch due to mechanical ventilation results in 
endothelial activation and inflammation in healthy mice, not only in the lung but also in 
organs distal to the lung (Hegeman et al, 2009). We observed that 4 hours of mechanical 
ventilation with high pressures, i.e. high level of alveolar stretch, induced de novo synthesis 
of various adhesion molecules in pulmonary but also in hepatic and renal tissue (figures 1a, 
e, i). In addition, increased cytokine and chemokine mRNA levels were found in the lung 
and distal organs after mechanical ventilation (figures 1b-c, f-g, j-k) accompanied by 
enhanced granulocyte infiltration (figures 1d, h, l). Our data imply that ventilator-induced 
endothelial activation in the lung, liver and kidney facilitates migration and adhesiveness of 
activated immune cells to inflamed tissue, which in turn may lead to tissue injury in these 
organs (Hegeman et al, 2009).  
Since we observed increased endothelial activation and inflammation after mechanical 
ventilation in the lung and distal organs, it seems plausible that mechanical ventilation plays 
a significant role in the development of both VILI and MOF (Hegeman et al, 2009). 
Supporting this hypothesis, earlier experimental research provided evidence that 
mechanical ventilation evokes detrimental effects in distal organs (Imai et al, 2003; Nin et al, 
2006). Imai et al. demonstrated that mechanical ventilation with high tidal volumes induces 
epithelial cell apoptosis in the kidney and small intestine (Imai et al, 2003). Moreover, these 
authors showed that mechanical ventilation leads to elevated levels of serum markers such 
as creatinine indicative for renal failure (Imai et al, 2003). Ventilator-induced cardiovascular 
and hepatic injury has been described as well (Nin et al, 2006). It should be noted that these 
previous studies used animals with pre-existing lung injury whereas our study used healthy 
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animals, suggesting that already existing inflammation is not a prerequisite for unveiling 
the negative effects of mechanical ventilation on distal organs. In line with this notion, a 
recent clinical trial showed that mechanical ventilation contributes to the development of 
acute kidney injury (AKI) in critically ill patients without ALI at onset of mechanical 
ventilation (Cortjens et al, 2011). Nonetheless, infectious events are known to aggravate 
ventilator-induced effects (Imai et al, 2003; O'Mahony et al, 2006) and possibly underlie the 
high incidence of MOF in critically ill patients ventilated with high tidal volumes and/or  
inspiratory pressures (Schultz, 2008). 
It remains to be determined which underlying mechanisms initiate the onset of endothelial 
activation and inflammation in distal organs during mechanical ventilation. Haitsma et al. 
and Tutor et al. demonstrated that ventilator-induced permeability of alveolar-capillary 
barriers provokes inflammatory mediator release into the blood circulation (Haitsma et al, 
2000; Tutor et al, 1994). Although there is quite some evidence that inflammatory mediators 
will be released from inflamed pulmonary tissue into the systemic environment, a causal 
relationship between ventilator-induced spill-over and the pathogenesis of MOF has not 
been confirmed yet.  
Our experimental data indicate that ventilator-induced changes in de novo expression of 
adhesion molecules, cytokines and chemokines occur simultaneously in the lung, liver and 
kidney (Hegeman et al, 2009). Moreover, granulocyte recruitment to the liver and kidney 
was already observed after 1 hour of mechanical ventilation (Hegeman et al, 2009). In view 
of this spatiotemporal pattern of inflammatory mediator expression, we suggest that release 
or spill-over of cytokines and chemokines from the lung into the blood circulation is 
probably not the only cause of the enhanced pro-inflammatory environment in distal organs 
during mechanical ventilation. It cannot be excluded, however, that inflammatory mediators 
released into the circulation may contribute to de novo synthesis of adhesion molecules, 
cytokines and chemokines in distal organs, since cytokines like IL-1┚ and TNF-┙ are known 
to induce the production of a host of inflammatory mediators (Goodman et al, 2003). Since 
cytokines have in general only a very short half-life in plasma (± 20 minutes), it is more 
logical that locally produced mediators dictate the level of distal organ involvement. Local 
induction of cytokines by e.g. oxygen-based free radicals may be another important pro-
inflammatory source in distal organs.  
Previously, it has been suggested that the physical stress of mechanical ventilation may 
trigger the sympathetic nervous system leading to an increase in catecholamine secretion 
(Plotz et al, 2004). Locally released catecholamines have been described to activate 
transcription factors like nuclear factor (NF)-κB in macrophages and promote production of 
IL-1β, TNF-α and IL-8 (Elenkov et al, 2000; Flierl et al, 2009; Spengler et al, 1990). These 
findings imply that stimulation of sympathetic nerve terminals in e.g. the liver and kidney 
may evoke a pro-inflammatory response in these peripheral organs (Elenkov et al, 2000; 
Straub et al, 2000). Subsequently, the presence of IL-1β, TNF-α and IL-8 may result in an 
acute phase response in the liver possibly via ┙–adrenergic activation (Elenkov et al, 2000; 
Flierl et al, 2009; Spengler et al, 1990). Based on these notions, we would like to propose that 
ventilator-induced activation of sympathetic nerve terminals in distal organs may contribute 
to the pro-inflammatory state of these organs. In turn, this pro-inflammatory state in distal 
organs may prime for the development of MOF in the critically ill patient (Imai et al, 2003; 
O'Mahony et al, 2006; Schultz, 2008). If so, modulation of adrenergic receptor function might 
be advantageous for the outcome of patients with MOF. Supporting this hypothesis, Miksa 
et al. showed in experimental models of sepsis that an ┙2A-adrenocepter antagonist reduced 
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plasma levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and 
creatinine, indicative for attenuated liver and kidney injury (Miksa et al, 2009). Moreover, 
these authors showed that inhibition of ┙2A-adrenocepter activation significantly improved 
survival in septic animals from 45 to 75% (Miksa et al, 2009).  
Another pathway of neuroimmune regulation is considered to be involved in the 
pathogenesis of VILI and MOF as well. In various inflammatory diseases, the efferent vagus 
nerve mediates anti-inflammatory action by downregulating pro-inflammatory immune 
responses (Kumar & Sharma, 2010). Recently, dos Santos et al. showed that disruption of the 
vagus nerve aggravates pulmonary wet-to-dry ratio, neutrophil infiltration, IL-6 production 
and apoptotic cell death, whereas stimulation of the vagus nerve was attenuating these 
parameters of VILI (dos Santos et al, 2011). These recent findings imply that the 
immunoregulatory function of the vagus nerve is of importance in VILI (dos Santos et al, 
2011). Also in systemic diseases like sepsis, vagus-mediated neuroimmune signaling has 
been suggested to be important (Kumar & Sharma, 2010). In this respect, Pavlov et al. 
revealed that pharmacological activation of the vagus nerve improved survival of septic 
mice by inhibiting pro-inflammation (Pavlov et al, 2007). Taken together, stimulating the 
cholinergic anti-inflammatory pathway by pharmacological agents may represent potential 
therapeutic intervention strategies in patients diagnosed with VILI and/or MOF. 
Besides an enhanced systemic pro-inflammatory milieu, it has been hypothesized that 
suppression of the peripheral immune system may also be crucially involved in the 
pathogenesis of MOF (Pinsky et al, 1993; Syrbe et al, 1994). Initially, suppression of the 
peripheral immune function may provide a compensatory mechanism to restore homeostasis 
under physiological circumstances (Bone, 1996). Yet, the compensatory reaction may become 
maladaptive when existing for prolonged periods of time consequently leading to excessive 
suppression of peripheral lymphocytes and augmented susceptibility to infections. In this 
respect, Angele and Faist reported that many ventilated, critically ill patients suffer from 
unexplained immune suppression and thus have an associated increased risk for infections 
and MOF (Angele & Faist, 2002). Therefore, locally enhanced production of cytokines by e.g. 
endothelial cells, hepatic or renal cells in the distal organs - in combination with a hampering 
immune function - may be detrimental for the patient to survive.  
Previously, we demonstrated that mechanical ventilation suppresses lymphocyte function 
outside the lung (Plotz et al, 2002; Vreugdenhil et al, 2004). In children without lung 
pathology, the functional capacity of peripheral blood leukocytes to produce TNF-┙, IL-6 and 
IFN-┛ in vitro was significantly reduced after 2 hours of mechanical ventilation (Plotz et al, 
2002). This was accompanied by a reduction in natural killer (NK) cell activity (Plotz et al, 
2002). Also in healthy rats, we observed that 4 hours of mechanical ventilation with high 
pressures suppressed peripheral immune functioning, i.e. reduced NK cell activity, mitogen-
induced splenocyte proliferation and cytokine production (Vreugdenhil et al, 2004). 
Supporting these earlier findings, 5 hours of HVT-ventilation resulted in diminished mitogen-
induced splenocyte proliferation compared to NVC in our murine model of VILI (figure 2).  
Taken together, our data indicate that mechanical ventilation does not only induce a pro-
inflammatory environment in organs distal to the lung, but also impairs the functioning of 
peripheral lymphocytes. Whether organ failure results from ongoing pro-inflammation of 
the environment (Pinsky et al, 1993) and/or persistent suppression of the immune function 
(Syrbe et al, 1994), these dysregulated immune responses may contribute to the 
development of MOF and subsequently cause increased morbidity and mortality in the 
critically ill patient (Rittirsch et al, 2008). 
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Fig. 2. Mechanical ventilation with high tidal volumes induces suppression of splenocyte 
proliferation.  
To investigate whether mechanical ventilation suppressed functioning of peripheral 
lymphocytes, healthy mice were mechanically ventilated for 5 hours with either low or high 
tidal volumes. Non-ventilated mice served as a reference group. In vitro mitogen-induced 
splenocyte proliferation was assessed as a measure of peripheral lymphocyte functioning. 
Splenocytes were stimulated in vitro with αCD3 (1µg/ml), a T cell specific antibody. After 48 
hours 3H-thymidine was added and 16 hours later incorporation of 3H-thymidine was 
determined. Data are depicted relative to LVT and expressed as mean ± SEM for n = 10-16 
animals. * p<0.05 (parameter was analyzed by one-way ANOVA with least significant 
difference (LSD) post-hoc test). NVC = non-ventilated controls; LVT, HVT = ventilated with 
either low or high tidal volumes. 
2.2 Alveolar-capillary permeability 
The primary site of pulmonary gas exchange is the < 0.2 µm thin part of the alveolar-
capillary membrane, consisting of alveolar epithelial and capillary endothelial cells (Burns et 
al, 2003; Weibel, 1984). Back in the 1980s, investigators observed that mechanical ventilation 
and the subsequent stretch of pulmonary tissue induces damage to epithelial-endothelial 
barriers thereby impairing gas exchange (Dreyfuss et al, 1985; Egan, 1982; Parker et al, 1984). 
In addition, Dreyfuss et al. demonstrated that enhanced microvascular permeability was 
responsible for the formation of pulmonary edema during mechanical ventilation with high 
tidal volumes (Dreyfuss et al, 1985). Besides apoptotic and/or necrotic cell death, loss of 
alveolar epithelial and capillary endothelial cell integrity is thought to play a crucial role in 
the ventilator-induced disruption of alveolar-capillary barriers (Pugin, 2003).  
2.2.1 Cell death 
Apoptosis is distinguished by cell shrinkage and nuclear fragmentation, while cell 
organelles and plasma membrane maintain their integrity for a prolonged period (Chang & 
Yang, 2000; Rossi & Gaidano, 2003). Apoptotic cell death is primarily regulated by cysteine 
aspartyl-specific proteases (caspases) and consists of two distinct routes: the intrinsic 
(mitochondria-mediated) and extrinsic (death receptor-mediated) pathway (Lavrik et al, 
2005a). In response to oxidative stress, DNA damage and other types of severe intracellular 
stress, mitochondria undergo marked changes in membrane integrity and activate the 
intrinsic apoptotic pathway (Denecker et al, 2001; Festjens et al, 2004). Enhanced 
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mitochondrial membrane permeability leads to release of pro-apoptotic proteins, like 
cytochrome c, from the mitochondria into the cytosol. Cytochrome c associates with 
apoptototic protease-activating factor (APAF)-1 and procaspase-9 to generate an 
apoptosome complex (Acehan et al, 2002; Jiang & Wang, 2000). In the apoptosome, 
procaspase-9 is cleaved to its mature form and activates the executioner caspase-3. 
Consequently, caspase-dependent DNAses are activated thereby causing chromatin 
condensation and DNA degradation (Chang & Yang, 2000). The extrinsic apoptotic pathway 
is initiated by triggering cell surface death receptors like the TNF receptor (TNFR)-1 and Fas 
(Lavrik et al, 2005b). Triggering of death receptors evokes formation of a death-inducing 
signaling complex (DISC) (Danial & Korsmeyer, 2004). The DISC brings procaspase-8 
molecules in close proximity to each other resulting in their autoproteolytic activation 
(Chang et al, 2003). After autocleavage of procaspase-8, active caspase-8 is released into the 
cytosol and cleaves important executioner caspases (Chang et al, 2003). Caspase-8 is also 
involved in an indirect pathway linking the extrinsic and intrinsic routes of apoptotic cell 
death (Korsmeyer et al, 2000; Zamzami & Kroemer, 2003). In this pathway, activation of 
caspase-8 leads to the cleavage of Bid to truncated Bid (tBid) which induces permeability of 
the mitochondrial membrane. An important mediator of both the intrinsic and extrinsic 
apoptotic pathway is p53, a tumor suppressor molecule (Haupt et al, 2003). P53 is a 
transcription factor for several Bcl-2 family genes, including Bid and Bax, thereby promoting 
cytochrome c release from mitochondria and initiating the intrinsic apoptotic pathway 
(Haupt et al, 2003). In addition, p53 induces APAF-1 expression which is required for 
formation of the apoptosome complex (Kannan et al, 2001). P53 may also initiate the 
extrinsic apoptotic pathway through induction of Fas and activation of caspase-8 (Ding et al, 
2000).  
Necrosis is characterized by irreversible plasma membrane damage, cytoplasmic swelling, 
organelle breakdown and, ultimately, cell rupture with leakage of cellular contents into 
the extracellular space (Fiers et al, 1999; Kroemer et al, 2005). Consequently, this type of 
cell death is associated with a marked inflammatory response. It has been proposed that 
necrosis might provide a backup suicide mechanism when caspase-dependent pathways 
of apoptosis cannot be properly activated (Fiers et al, 1999; Leist & Jäättelä, 2001) although 
this hypothesis may be too simplistic. Depletion of adenosine triphosphate (ATP) for 
instance may favor a switch from apoptosis to necrosis, in part because ATP is necessary 
for optimal activation of caspases (Leist et al, 1997). For many years, necrosis has been 
considered to be an uncontrolled process. However, recent evidence suggests that the 
course of necrotic cell death might be as tightly regulated as apoptotic cell death (Festjens 
et al, 2006; Golstein & Kroemer, 2007). It has to be kept in mind though, that necrotic and 
apoptotic traits might co-exist (Kroemer et al, 2009) and that the same cell death inducers 
may promote either necrosis or apoptosis depending on the specific environmental setting 
(Galluzzi et al, 2009). In this regard, previous research showed that triggering of TNFR-1 
by TNF does not only lead to activation of the extrinsic pathway of apoptosis but also to 
programmed necrosis involving receptor-interacting protein (RIP) kinases (Galluzzi et al, 
2009; Hitomi et al, 2008). Data from Cho et al., He et al. and Zhang et al. implicate RIP3 as 
a pivotal switch between TNF-induced apoptosis and necrosis (Cho et al, 2009; He et al, 
2009; Zhang et al, 2009a). Based on this notion, the protein complex containing RIP1/RIP3 
has been proposed to function as a “necrosome” (Declercq et al, 2009). In this setting, RIP3 
promotes mitochondrial dysfunction, subsequent production of reactive oxygen species 
(ROS) and eventually necrotic cell death. Besides the production of ROS, necrotic cell 
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death is associated with sustained elevation of cytosolic calcium levels (Harwood et al, 
2005). Calcium overload leads to activation of calcium-dependent cysteine proteases, 
calpains. Active calpains promote release of lysosomal catabolic aspartyl proteases, 
cathepsins, which cleave essential cytoskeletal components like spectrin (also known as 
fodrin), microtubule subunits and microtubule-associated proteins thereby resulting in 
enhanced destabilization of the cell and ultimately in necrotic cell death (Artal-Sanz & 
Tavernarakis, 2005; Zhang et al, 2009b).  
Apart from necrosis, autophagy has been recognized as a distinct form of non-apoptotic cell 
death. Authophagy is the main cellular pathway for degradation of damaged cytoplasmic 
organelles or denatured proteins (Levine & Klionsky, 2004). In response to stress (e.g. 
hyperoxia, oxidative stress, pro-inflammation), autophagic vacuoles sequester damaged 
organelles or proteins. Subsequently, autophagic vacuoles fuse with lysosomes where the 
internalized contents will be degraded by lysosomal enzymes like cathepsins (Ryter & Choi, 
2010). While basal activation of autophagy ascertains the physiological turnover of 
cytoplasmic organelles and proteins, dysregulation or excessive activation of autophagy 
may induce non-apoptotic cell death (Galluzzi et al, 2008; Maiuri et al, 2007). A potential 
cross-talk has been proposed between the mechanisms that regulate autophagy and those 
regulating apoptosis or necrosis (Galluzzi et al, 2008).  
Cell death has been considered to play a crucial role in the disruption of alveolar-capillary 
barriers (Pugin, 2003). Previously, in vitro studies demonstrated that mechanical stretch 
may activate apoptotic cell death (dos Santos et al, 2004; Edwards et al, 1999; 
Hammerschmidt et al, 2004). Moreover, several investigators reported enhanced 
apoptosis after 2 to 5 hours of mechanical ventilation with high tidal volumes (Chiang et 
al, 2011; Le et al, 2008; Li et al, 2007). Although the precise role of necrotic cell death has 
not been elucidated in VILI yet, it has been demonstrated in vitro that mechanical stretch 
as such induces necrosis (Hammerschmidt et al, 2004; Tschumperlin et al, 2000). 
Therefore, we investigated whether apoptotic and/or necrotic cell death pathways were 
activated in lungs of healthy mice exposed to either 5 hours of LVT or HVT-ventilation. 
Protein expression of cleaved caspase-8, -9 and -3 was determined in total lung 
homogenates as measures of caspase-dependent cell death. Protein expression of cleaved 
┙-fodrin (145/150kDa fragments yielded by calcium-activated calpains) was determined 
as a measure of caspase-independent cell death. Our data demonstrate unequivocally that 
basal cleavage of caspase-8 was not enhanced by LVT or HVT-ventilation (figure 3a). 
Furthermore, cleaved caspase-9 and -3 were below detection level in all experimental 
groups implying that caspase-dependent pathways of apoptosis were not activated. 
Cleaved ┙-fodrin levels, however, were significantly increased in lungs of ventilated mice 
in comparison to NVC, which was independent of ventilation strategy (figure 3b). On the 
basis of these findings, it is tempting to speculate that 5 hours of mechanical ventilation 
induces cell death primarily via caspase-independent necrotic pathways. In contrast to 
our present data, Wolthuis et al. observed in a comparable model of VILI that the number 
of caspase 3-positive cells on lung sections was higher in HVT-ventilated mice than in 
control animals although this increase did not reach statistical significance (p=0.055) 
(Wolthuis et al, 2009a). Taken together, we propose that apoptosis is not the major 
executive mechanism of cell death in our experimental model of VILI. Nonetheless, we 
cannot exclude that caspase-dependent pathways of cell death are modestly activated 
which - together with necrotic activities induced in the target cell - will determine the 
level of cell death.  
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Fig. 3. Mechanical ventilation activates caspase-independent pathways of cell death. 
To investigate whether mechanical ventilation activated caspase-dependent and/or caspase-
independent pathways of cell death, healthy mice were mechanically ventilated for 5 hours 
with either low or high tidal volumes. Non-ventilated mice served as a reference group. A: 
In total lung homogenates, protein expression of cleaved caspase-8 was determined by 
Western blotting as a measure for activation of caspase-dependent cell death pathways. 
Cleaved caspase-9 and -3 were below detection level in all experimental groups. B: In 
addition, protein expression of cleaved ┙-fodrin (145/150kDa fragments yielded by calcium-
activated calpains) was determined as a measure for activation of caspase-independent cell 
death pathways. Levels were normalized for total protein levels (Coomassie staining). Inset: 
representative Western blot depicting immunodetectable cleaved capase-8 and ┙-fodrin, 
respectively. Data are depicted relative to NVC and expressed as mean ± SEM for n = 5-8 
animals. * p<0.05, *** p<0.001 (parameters were analyzed by one-way ANOVA with least 
significant difference (LSD) post-hoc test). NVC = non-ventilated controls; LVT,  
HVT =  ventilated with either low or high tidal volumes. 
2.2.2 Loss of vascular integrity 
Under normal conditions, quiescent vascular endothelium establishes a tight barrier which 
controls the movement of plasma and/or leukocytes from the circulation into the 
underlying tissue (Cines et al, 1998). To achieve this barrier function, tight cell-cell contacts 
are formed by junctional transmembrane proteins such as vascular endothelial (VE)-
cadherin (Dejana, 2004). Vascular leakage is an important feature of inflammatory disorders 
and is predominately caused by hyperpermeability of the endothelial barrier (Lentsch & 
Ward, 2000; Michel & Curry, 1999). 
One of the crucial systems regulating vascular cell integrity is the angiopoietin (Ang)-Tie2 
system (Fiedler & Augustin, 2006). Ang-1 and Ang-2 are, respectively, an agonist and 
antagonist of the tyrosine kinase receptor Tie2 (Fiedler et al, 2003). Constitutive Ang-1 
expression and Tie2 phosphorylation in adult vasculature implies that Ang-1−mediated Tie2 
signaling is required to maintain endothelial cell integrity and quiescence (Fiedler & 
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Augustin, 2006). Binding of Ang-1 leads to autophosphorylation of Tie2, subsequently 
activating several intracellular signaling pathways and maintaining endothelial cell integrity 
(Fiedler & Augustin, 2006). One of the signal transduction routes initiated upon Tie2 
activation is the phosphatidylinositol 3 kinase (PI3K)–Akt pathway, which in general 
promotes cell survival (DeBusk et al, 2004; Kim et al, 2000; Papapetropoulos et al, 2000). In 
this regard, it has been shown that Ang-1−mediated Tie2 signaling may prevent endothelial 
cell apoptosis by activating Akt and upregulating survivin, an apoptosis inhibitor 
(Papapetropoulos et al, 2000). Daly et al. proposed a molecular mechanism through which 
Ang-1−mediated Akt activation may promote vascular stability (Daly et al, 2004). These 
authors demonstrated that Akt activation inactivates the forkhead transcription factor FKHR 
(FOXO1) which regulates genes associated with endothelial cell apoptosis (survivin) and 
vascular destabilization (Ang-2) (Daly et al, 2004). These findings imply that Ang-
1−mediated Tie2 signaling prevents Ang-2 expression and subsequent loss of vascular 
integrity. Another signal transduction route that may be influenced upon Tie2 
phosphorylation is the NF-κB pathway. Hughes et al. showed that Tie2 interacts with A20-
binding inhibitor of NF-κB (ABIN)-2, a NF-κB regulatory protein (Hughes et al, 2003). As a 
consequence of ABIN-2 recruitment, Ang-1-mediated Tie2 signaling inhibits activation of 
the NF-κB pathway and results in an anti-inflammatory and quiescent status of the 
endothelial barrier (Hughes et al, 2003). Finally, Gavard et al. described that Ang-
1−mediated Tie2 signaling protects against vascular endothelial growth factor (VEGF)-
stimulated endothelial permeability by inhibiting VEGF-triggered endocytosis of VE-
cadherin, a junctional transmembrane protein establishing tight cell-cell contacts (Gavard et 
al, 2008). Until now, an increase in Ang-2 levels has been recognized to be the modulating 
factor of the Ang-Tie2 system. In situations of endothelial activation, Ang-2 proteins are 
released from endothelial specific storage granules (Weibel-Palade bodies) and compete 
with Ang-1 for binding to the Tie2 receptor (Fiedler & Augustin, 2006). Accordingly, Ang-2 
may exert antagonistic functions on Ang-1−mediated Tie2 signaling and alter vascular 
integrity, destabilize the endothelial barrier and prime the endothelium to attain 
responsiveness to pro-inflammatory mediators (Fiedler & Augustin, 2006). In line with this, 
van der Heijden et al. demonstrated that circulating Ang-2 and increased Ang-2/Ang-1 
ratios are related to pulmonary permeability edema and severity of ALI/ARDS in ventilated 
patients with or without sepsis (van der Heijden et al, 2008). Furthermore, Gallagher et al. 
showed that high circulating Ang-2 levels in ALI/ARDS patients are associated with a poor 
outcome (Gallagher et al, 2008). Since 67% of these ALI/ARDS patients were mechanically 
ventilated, the authors proposed that ventilatory support alone does not cause enhanced 
Ang-2 levels (Gallagher et al, 2008). However, there is also conflicting evidence that Ang-2 
may induce Tie2 activation in stressed endothelial cells (Daly et al, 2006). 
Both clinical and experimental studies recognized the importance of the Ang-Tie2 system in 
the pathogenesis of lung diseases related to VILI, like ALI and ARDS (van der Heijden et al, 
2009). Karmpaliotis et al. demonstrated that vascular permeability and pulmonary edema 
were accompanied by reduced Ang-1 and enhanced VEGF levels in lungs of 
lipopolysaccharide (LPS)-challenged mice (Karmpaliotis et al, 2002). The same authors 
proposed that changes in the balance between Ang-1 (anti-leakage) and VEGF (pro-leakage) 
might contribute to the pathophysiology of ALI (Karmpaliotis et al, 2002).  
It may well be that a disturbed balance between Ang-1 and VEGF plays an indispensable 
role in VILI as well. Therefore, we examined whether 5 hours of either LVT or HVT-
ventilation would influence the Ang-Tie2 system and VEGF expression in lungs of healthy 
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mice (Hegeman et al, 2010). Particularly in lungs of HVT-ventilated mice, marked changes in 
the Ang-Tie2 system were observed. We demonstrated that Ang-1, Ang-2 and Tie2 mRNA 
expression was significantly reduced in HVT-ventilated mice in comparison with NVC 
(figures 4a-c). At this time point, Ang-1 and Ang-2 protein expression also tended to 
decrease (figures 4d-f). Moreover, we observed that HVT-ventilation caused increased 
expression of VEGF (figure 4g) which is in agreement with a prior report (Nin et al, 2008). 
Our findings strongly suggest that changes in the Ang-Tie2 system, together with elevated 
VEGF expression, are involved in the development of VILI  (Hegeman et al, 2010).  
 
 
Fig. 4. Mechanical ventilation affects the angiopoietin (Ang)-Tie2 system and vascular 
endothelial growth factor (VEGF) expression. 
Reprinted with permission of PLoS One (Hegeman et al, 2010). To investigate whether 
mechanical ventilation influences the Ang-Tie2 system, healthy mice were mechanically 
ventilated for 5 hours with high tidal volumes. Non-ventilated mice served as a reference 
group. A-C: In total lung homogenates, mRNA expression of Ang-1, Ang-2 and Tie2 was 
determined by real-time RT-PCR. Levels were normalized for expression of internal 
controls, i.e. the average value of ┚-actin and glyceraldehyde 3-phospate dehydrogenase 
(GAPdH). D-E: In total lung homogenates, protein expression of Ang-1 and Ang-2 was 
determined by Western blotting. Membranes were reprobed with antibody recognizing total 
Akt (Akt1/PKB┙) to control for equal loading. No group differences in total Akt were 
found. Inset: representative Western blot depicting immunodetectable Ang-1 and Ang-2, 
respectively. F-G: In total lung homogenates, protein expression of Tie2 and VEGF was 
determined by ELISA. Levels were normalized for total protein concentrations. Data are 
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depicted relative to NVC and expressed as mean ± SEM for n = 6-12 animals. *** p<0.001 
(parameters were analyzed by independent T-test). NVC = non-ventilated controls; HVT = 
ventilated with high tidal volumes. 
In addition to the Ang-Tie2 system, Rho guanosine triphosphatases (GTPases) are 
recognized to be crucially involved in the mechanosensitive regulation of vascular 
permeability (Birukov, 2009; Spindler et al, 2010). Rho GTPases act as molecular switches 
that regulate a wide variety of signal transduction pathways involved in cell behavior 
(Schmidt & Hall, 2002; Wojciak-Stothard & Ridley, 2002). Rho GTPases cycle between an 
active guanosine triphosphate (GTP)-bound and an inactive guanosine diphosphate (GDP)-
bound conformational state. Switching between the active and inactive form is tightly 
regulated. Guanine nucleotide exchange factors (GEFs), for example, promote the exchange 
from GDP to GTP leading to activation of Rho GTPases (Wojciak-Stothard & Ridley, 2002).  
Rac1 and Cdc42 are the main Rho GTPases needed for maintaining endothelial barrier 
function, whereas RhoA primarily has a destabilizing effect on endothelial barrier properties 
(Spindler et al, 2010). RhoA activation has been described to induce formation of stress 
fibers comprising actin and myosin (Ridley & Hall, 1992; Wojciak-Stothard et al, 1998). 
Consequently, actin-myosin contractility is suggested as the major mechanism of RhoA-
mediated impairment of endothelial barrier properties (Spindler et al, 2010). RhoA signals 
through a downstream effector kinase, so-called Rho-kinase or Rho-associated coiled-col 
forming kinase (ROCK) (Liao et al, 2007). Activation of ROCK by RhoA inhibits myosin 
phosphatase acitivty subsequently leading to myosin light chain phosphorylation and stress 
fiber formation  (Amano et al, 1997; Kimura et al, 1996).  
3. Therapeutic interventions in critically ill patients with ventilator-induced 
lung injury 
The recognition that conventional mechanical ventilation itself provokes detrimental effects 
in ventilated patients has led to the introduction of “lung-protective” ventilation strategies 
(Gillette & Hess, 2001). So far, mechanical ventilation with reduced tidal volumes is the only 
therapeutic approach effectively attenuating pulmonary injury and subsequent morbidity 
and mortality in critically ill ALI/ARDS patients (Amato et al, 1998; the ARDS network, 
2000; Villar et al, 2006). In this regard, the ARDS Network revealed a 22% relative risk 
reduction in mortality rate when ventilating ALI/ARDS patients with “lung-protective” 
strategies, i.e. mechanical ventilation with tidal volumes of 6 ml/kg instead of with  
12 ml/kg (the ARDS network, 2000). Notably, Determann et al. showed mechanical 
ventilation with lower tidal volumes also to attenuate development of lung injury in 
patients without ALI at the onset of mechanical ventilation (Determann et al, 2010). Recent 
research however, provided striking evidence that even “lung-protective” ventilator settings 
may result in the development of important aspects of VILI (Cobelens et al, 2009; Vaneker et 
al, 2007; Wolthuis et al, 2009b). We confirmed these prior reports in a murine model of VILI. 
We observed that not only conventional ventilation strategies with high tidal volumes but 
also clinically relevant ventilation strategies with low tidal volumes causes inflammation 
and vascular leakage in the lung (Hegeman et al, 2010; Hegeman et al, 2011b). Interestingly, 
a recent clinical trial revealed that mechanical ventilation with tidal volumes of 6ml/kg did 
not protect against the development or worsening of AKI in critically ill patients without 
ALI at onset of mechanical ventilation (Cortjens et al, 2011).  
Apart from preserving alveolar integrity by reducing tidal volumes, additional therapeutic 
intervention strategies that prevent the detrimental effects of mechanical stretch are therefore 
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urgently needed. Based on the mechanisms that may underlie the pathogenesis of VILI (as 
mentioned above), therapies manipulating the course of inflammation and/or alveolar-
capillary permeability might be advantageous for the clinical outcome of ventilated patients. 
3.1 Inhibition of ventilator-induced lung inflammation: does it preclude lung injury? 
It has been recognized that granulocytes and inflammatory mediators are important in the 
pathogenesis of VILI (Haitsma et al, 2003; Wilson et al, 2003; Wilson et al, 2005). 
Consequently, anti-inflammatory agents like glucocorticoids are suggested to attenuate or 
prevent the detrimental effects induced by mechanical ventilation (Brower et al, 2001; Luce, 
2002). Glucocorticoids are a class of steroid hormones that exert their anti-inflammatory and 
immunosuppressive effects by binding to intracellular glucocorticoid receptors (GRs). After 
binding, the GR complex migrates from the cytosol to the nucleus where it regulates a wide 
range of gene activity, including inhibition of NF-κB and activator protein (AP)-1 driven 
expression of inflammatory genes (Barnes, 2006). Furthermore, glucocorticoids are known to 
suppress granulocyte recruitment and activation, preserve endothelial cell integrity and 
control vascular permeability (Ohta et al, 2001; Thompson, 2003). Although the efficacy of 
synthetic glucocorticoids to treat ALI/ARDS in critically ill patients is still under debate 
(Agarwal et al, 2007; Fernandes et al, 2005; Meduri et al, 2008), previous experimental 
research demonstrated that glucocorticoid treatment has the potential to attenuate 
ventilator-induced lung inflammation (Held et al, 2001; Ohta et al, 2001).  
Unfortunately, the anti-inflammatory effects of synthetic glucocorticoids cannot be separated 
from their metabolic effects. In particular when given at higher doses and for longer periods, 
systemic administration of glucocorticoids is associated with severe side effects like elevated 
blood glucose levels, deposition of body fat, suppressed systemic immunity and increased 
susceptibility to infections (Schacke et al, 2002). One way to reduce the unwanted side effects 
of glucocorticoid treatment is to selectively deliver these therapeutic agents into the diseased 
tissue (Asgeirsdottir et al, 2007). In this respect, liposomal formulations are valuable drug 
delivery systems as they can act as a depot from which the encapsulated drug will be slowly 
released to enable prolonged, local drug exposure at low concentrations (Storm & Crommelin, 
1998). Moreover, liposomes preferably extravasate into tissues with increased capillary 
permeability (Storm & Crommelin, 1998) facilitating delivery at sites of inflammation and/or 
mechanical stretch. Previously, Ásgeirsdóttir et al. clearly showed that delivery of liposome-
encapsulated dexamethasone inhibits pro-inflammatory gene expression without affecting 
blood glucose levels (Asgeirsdottir et al, 2007), one of the first clinically relevant side effects of 
free dexamethasone treatment (Feldman-Billard et al, 2006; Weinstein et al, 1995). Because 
local delivery of glucocorticoids by liposomal formulations could be of therapeutic importance 
in the context of VILI as well, we studied whether liposomes containing dexamethasone (Dex-
liposomes) inhibited ventilator-induced lung inflammation (Hegeman et al, 2011a). We 
observed that administration of Dex-liposomes at initiation of ventilation diminished crucial 
inflammatory parameters of VILI such as IL-1┚, IL-6 and KC mRNA expression, especially in 
LVT-ventilated mice (Hegeman et al, 2011a). Yet, this formulation was not as effective as free 
dexamethasone in preventing granulocyte infiltration into pulmonary tissue (Hegeman et al, 
2011a). As granulocytes are considered to be important in the development of VILI (Kawano et 
al, 1987), we hypothesized that phagocytosis of liposomes by activated granulocytes may be 
advantageous and should therefore be enhanced (Hegeman et al, 2011a). We proposed that 
IgG-modified Dex-liposomes (IgG-Dex-liposomes) may be more efficient in attenuating 
ventilator-induced lung inflammation than Dex-liposomes due to interaction with Fc┛-
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receptors (Fc┛Rs) on activated granulocytes and macrophages (McKenzie & Schreiber, 1998). 
Indeed, IgG-Dex-liposomes were pharmacologically more effective than Dex-liposomes 
particularly in preventing granulocyte infiltration induced by either LVT or HVT-ventilation 
(Hegeman et al, 2011a). Additionally, IgG-Dex-liposomes inhibited most parameters of 
ventilator-induced lung inflammation as efficient as free dexamethasone. Our experimental 
data imply that conjugation of IgG to Dex-liposomes significantly improves their efficacy in 
attenuating ventilator-induced lung inflammation (Hegeman et al, 2011a). Importantly, the use 
of liposomes may favor local release of dexamethasone thereby preventing unwanted systemic 
side effects (Asgeirsdottir et al, 2007). 
At present, it is thought that ventilator-induced lung inflammation may precede lung 
injury. Therefore, we hypothesized that reducing the inflammatory response by 
therapeutic intervention strategies would prevent vascular leakage and impaired gas 
exchange associated with mechanical ventilation. We observed, however, that the potent 
anti-inflammatory agent dexamethasone did not prevent occurrence of the more crude 
parameters of VILI like the elevation in BALf protein level, the increase in pulmonary 
wet-to-dry ratio and the reduction in PaO2/FiO2 ratio (Hegeman et al, 2011b). Our 
findings oppose previous studies describing protective effects of glucocorticoid therapy 
on lung injury (Nin et al, 2006; Ohta et al, 2001). In a rat model of VILI, dexamethasone 
was shown to restore pulmonary function after 75 minutes of mechanical ventilation as 
indicated by improved PaO2/FiO2 ratios (Nin et al, 2006). Moreover, Ohta et al. 
demonstrated that administration of methylprednisolone caused a marked leftward 
shifting of the pressure-volume (P-V) curve of rats ventilated for 40 minutes (Ohta et al, 
2001). However, the deterioration of the P-V curve was still evident regardless of the  
significant reduction in granulocyte infiltration (Ohta et al, 2001). Ohta et al. explained 
these findings by the effects of mechanical stretch on lung tissue like stress failure of 
pulmonary capillaries, which may contribute to lung injury to a great extent (Ohta et al, 
2001; West et al, 1991). Since mice were exposed to 5 hours of mechanical ventilation in 
our experimental model of VILI, it is tempting to speculate that the progressive lung 
injury induced by prolonged mechanical stretch may not be influenced by the anti-
inflammatory action of dexamethasone (anymore).  
Similar to dexamethasone, administration of the vessel protective factor Ang-1 only 
inhibits inflammatory aspects of VILI (Hegeman et al, 2010). In a murine model of VILI, 
we observed that intravenous Ang-1 treatment at initiation of ventilation inhibited 
granulocyte infiltration and inflammatory mediator release, and completely abolished the 
increase in VEGF protein in lungs of HVT-ventilated mice (Hegeman et al, 2010). 
Although Ang-1 was preventing development of these important aspects of VILI, it did 
not influence the end points of VILI such as vascular leakage and impaired gas exchange 
(Hegeman et al, 2010). Our data are in apparent contrast with previously reported 
protective effects of Ang-1 on vascular leakage in endotoxin-challenged animals (Huang 
et al, 2008; McCarter et al, 2007; Mei et al, 2007; Witzenbichler et al, 2005). Using a similar 
dosing and administration procedure of Ang-1, David et al. showed that Ang-1 therapy 
also stabilized endothelial barrier function in an murine model of polymicrobiological 
abdominal sepsis as evidenced by attenuation of protein leakage from lung capillaries into 
the alveolar compartment (David et al, 2011). These findings underline that the pathways 
involved in sepsis- and ventilator-induced lung injury are different. An explanation for 
this discrepancy might be that the enhanced inflammation is not the primary inducer of 
vascular leakage and impaired gas exchange during HVT-ventilation as is the case in the 
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induction of lung injury by sepsis. Indeed, it has been shown that ventilator-induced 
mechanical stretch itself may destabilize alveolar-capillary barrier function thereby 
resulting in increased vascular permeability and pulmonary edema (Dreyfuss et al, 1985; 
Egan, 1982; Parker et al, 1984). Ang-1 treatment will probably affect the capillary-
endothelial but not the alveolar-epithelial barrier since the Tie2 receptor is mainly 
expressed on endothelial cells (Lemieux et al, 2005). Thus, the possibility remains that 
Ang-1 treatment is not capable of restoring lung injury induced by HVT-ventilation as it 
only modulates endothelial inflammation (Hegeman et al, 2010). The fact that Ang-1 
prevents pulmonary vascular leakage in animals exposed to LPS, which induces a 
generalized inflammation primarily in the endothelial cells of the lung (Weppler & 
Issekutz, 2008), supports this hypothesis. In this respect, it is of interest that the TNF-α 
inhibitor Etanercept diminished inflammation and coagulation in the lungs of ventilated 
mice without affecting alveolar-capillary permeability and pulmonary edema (Wolthuis et 
al, 2009a), which is in line with our findings.  
Taken together, we would like to suggest that prevention of lung inflammation does not 
preclude a loss of pulmonary function in our experimental model of VILI, in contrast to 
what has been shown in models of endotoxin- or sepsis-induced ALI. Probably the 
mechanism of injury caused by mechanical ventilation is different from the injury caused by 
endotoxin-challenge. In this regard, our in vivo studies revealed that endotoxin-challenge 
provokes lung injury via both caspase-dependent apoptosis and caspase-independent 
necrosis (unpublished data by Kooijman et al.). Lung injury induced by either LVT or HVT-
ventilation, however, is for the greater part caspase-independent and probably executed by 
pathways involving destabilization of the cytoskeleton via proteolytic activity of calpains 
(figure 3). Thus, the primary functional deficit induced by mechanical ventilation may be 
more geared at early cellular death due to alveolar (over)stretch which will most likely not 
be counteracted by anti-inflammatory intervention strategies. 
3.2 Focus of future therapeutic interventions  
We have clearly shown that anti-inflammatory intervention strategies do not prevent 
aspects of VILI driven by mechanosensitive alterations in barrier properties but will only 
regulate the pulmonary inflammation (Hegeman et al, 2010; Hegeman et al, 2011b). It may 
well be that it is difficult to diminish the effect of mechanical stretch on lung injury solely by 
anti-inflammatory therapy. So, we now propose that anti-inflammatory agents should not 
be applied to combat the mechanosensitive aspects of VILI. However, anti-inflammatory 
intervention strategies may well be considered when inflammation is the primary inducer of 
lung injury like in non-ventilated patients diagnosed with ALI or ARDS.  
3.2.1 Inhibitors of RhoA and/or ROCK 
Our findings imply that future therapeutic interventions in the ventilated, critically ill patient 
should aim at attacking the ventilator-induced impairment of alveolar-capillary barrier 
function. As Rho GTPases have been described to be important in the mechanosensitive 
regulation of endothelial barrier function (Birukov, 2009), inactivation of RhoA and/or ROCK  
may have a protective effect on endothelial barrier function in the context of VILI. In this 
respect, we investigated the effects of the selective ROCK inhibitor Y-27632 in a rat model of 
LPS-induced ALI (unpublished data by Kooijman et al.). ROCK inhibition significantly 
diminished endothelial permeability in LPS-challenged lungs, which was associated with 
decreased pulmonary inflammation and suppressed activation of caspase-dependent and 
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caspase-independent cell death pathways. Our results are supported by previous studies in 
experimental models of ALI. Tasaka et al. showed that treatment with the ROCK inhibitor Y-
27632 attenuated pulmonary edema formation and neutrophil infiltration induced by LPS 
(Tasaka et al, 2005). Also in an experimental model of oleic acid-induced ALI, ROCK inhibition 
resulted in diminished lung injury as demonstrated by improved lung histology and reduced 
myeloperoxidase (MPO) activity (Koksel et al, 2005). Together these data imply that ROCK 
inhibition might be a beneficial therapeutic strategy in preventing lung injury, at least in the 
absence of mechanosensitive aspects of mechanical ventilation.  
GEF inhibitors may be superior to direct pharmacological inhibitors of RhoA or ROCK 
(Birukova et al, 2010). Pharmacological targeting of GEF enables inhibition of excessive Rho 
signaling resulting from pathological conditions, while basal RhoA activity will remain 
unchanged. GEF factor H1 (GEF-H1) has been characterized as a RhoA-specific GEF (Ren et 
al, 1998). Consequently, (excessive) activation of GEF-H1 is associated with endothelial 
permeability. Evidence for the importance of GEF-H1 in endothelial barrier dysfunction has 
been provided by Birkova et al. (Birukova et al, 2006; Birukova et al, 2010). These authors 
showed that small interfering (si)RNA-based knockdown of GEF-H1 abolished Rho 
signaling, stress fiber formation and permeability in an in vitro model of cell stretch 
(Birukova et al, 2010). Depletion of GEF-H1 also showed to attenuate vascular leakage in a 
murine model of VILI (Birukova et al, 2010). In view of these findings, GEF-H1 might be an 
attractive target to prevent the detrimental effects induced by the pathological 
mechanosensitive aspects associated with mechanical ventilation. 
3.2.2 Inhibitors of cell death 
Pulmonary cell death is thought to be involved in the ventilator-induced disruption of 
alveolar-capillary barriers and thus in the impairment of alveolar-capillary barrier function 
(Pugin, 2003). In lungs of LVT and HVT-ventilated mice, we observed elevated protein levels 
of cleaved α-fodrin, but not of cleaved caspases, signifying that 5 hours of mechanical 
ventilation primarily activates the caspase-independent cell death pathway (figure 2). In 
view of this notion, it would be of interest to evaluate the effects of calpain inhibitors in our 
experimental model of VILI. Protective effects of calpain inhibitors have already been shown 
in experiment models of inflammation (Cuzzocrea et al, 2000; Cuzzocrea et al, 2002; Rose et 
al, 2006).  Cuzzocrea et al. described that treatment with calpain inhibitors diminishes 
granulocyte infiltration, lipid peroxidation and the degree of lung injury caused by 
intrapleural injection of carrageenan, a polysaccharide extracted from seaweed (Cuzzocrea 
et al, 2000). In addition, the same research group demonstrated that calpain inhibitors may 
decrease the degree of lung inflammation and injury induced by zymosan, which leads to 
the formation of reactive oxygen species (Cuzzocrea et al, 2002). More importantly, these 
authors demonstrated that inhibition of calpain activity did not only attenuate inflammation 
and injury in the lung but also in organs like the liver and intestine (Cuzzocrea et al, 2002). 
As we observed that mechanical ventilation with high pressures induces marked 
inflammation in both the lung and distal organs (Hegeman et al, 2009), treatment with 
calpain inhibitors may be beneficial in ventilated patients suffering from respiratory failure 
and/or MOF.  
For many years, necrosis has been considered to be an uncontrolled process. However, 
recent evidence suggests that the course of necrotic cell death might be as tightly regulated 
as apoptotic cell death (Festjens et al, 2006; Golstein & Kroemer, 2007). It has to be kept in 
mind though, that necrotic and apoptotic traits may co-exist (Kroemer et al, 2009) and the 
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same cell death inducers may promote either necrosis or apoptosis depending on the 
specific environmental setting (Galluzzi et al, 2009). Triggering of TNFR-1 by TNF-┙ does 
not only lead to activation of the extrinsic pathway of apoptosis but also to programmed 
necrosis involving RIP-kinases (Galluzzi et al, 2009; Hitomi et al, 2008). Necrostatin has been 
described as a small molecule inhibitor of programmed cell necrosis which prevents RIP1 
kinase activation (Degterev et al, 2005). Importantly, previous research already showed that 
inhibition of programmed cell necrosis by necrostatin protects against the development of 
brain injury (Degterev et al, 2005; Northington et al, 2011; You et al, 2008). Northington et al. 
described that necrostatin exerts its protective effects by inhibition of the RIP1-RIP3 
interaction, decreased oxidative injury and suppression of the pro-inflammatory response 
(Northington et al, 2011). The effect of necrostatin has not yet been evaluated in models of 
lung injury which are clearly associated with increased cell death, oxidative injury and pro-
inflammation. Since mechanical ventilation in our experimental model of VILI primarily 
activated the caspase-independent route of cell death, treatment with necrostatin might be a 
preventive strategy for the devastating mechanosensitive effects of mechanical ventilation.  
3.2.3 Mesenchymal stem cells 
Adult stem cells have retained the ability to differentiate into a variety of cell lineages 
(McCulloch & Till, 2005). One of the most well characterized adult stem cells are the 
mesenchymal stem cells (MSCs) (Pittenger et al, 1999). MSCs can be isolated from various 
tissues such as bone marrow, placenta and adipose tissue. MSCs have been described to 
home to injured tissue beds, interact with injured cells and secrete multiple paracrine factors 
that regulate endothelial and epithelial permeability, decrease inflammation, enhance tissue 
repair and inhibit bacterial growth (Lee et al, 2011). In addition, MSC therapy may support 
endogenous stem cells residing in pulmonary tissue (Lee et al, 2011). In view of these 
notions, cell–based therapy with MSCs has been proposed as a potential intervention 
strategy for severe lung diseases.  
Previously, MSCs have been shown to restore function of damaged tissue in experimental 
models of lung disease. To our knowledge, the effecs of MSCs were primarily studied in 
rodent models of ALI. In this regard, intravenous MSC administration reduced lung 
inflammation and prolonged survival in a murine model of bleomycin-induced lung injury 
and fibrosis (Ortiz et al, 2003; Rojas et al, 2005). Similar effects of MSC treatment have been 
described in murine models of endotoxin–induced lung injury (Mei et al, 2007; Xu et al, 
2007; Xu et al, 2008). Xu et al. observed that intravenous MSC administration prevents 
endotoxin-induced lung injury, edema formation and inflammation in mice (Xu et al, 2007). 
Moreover, genetic engineering of MSCs showed to improve the protective effects of MSCs 
even more (Mei et al, 2007; Xu et al, 2008). Mei et al. evaluated the integrity of the alveolar-
capillary membrane barrier by measuring total protein, albumin and IgM concentration in 
BALf in a murine model of LPS-induced ALI (Mei et al, 2007). They showed that treatment 
with MSCs alone already partially reduced these indicators of lung injury in LPS-exposed 
mice. MSCs overexpressing the vessel protective factor Ang-1, however, restored total 
protein, albumin and IgM to levels not different from naive control animals (Mei et al, 2007). 
It should be noted though, that mechanical ventilation provokes a different spectrum of 
pulmonary injury compared to LPS-challenge as demonstrated by the difference in efficacy 
of Ang-1 treatment in our model of VILI (Hegeman et al, 2010). Nonetheless, it is tempting 
to speculate that autologous stem cell transplantation could become a beneficial approach to 
protect ventilated patients against detrimental effects induced by mechanical ventilation. 
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Although mechanical ventilation is a life-saving procedure in the ICU, it has the potential to 
aggravate or even induce detrimental effects (Dreyfuss & Saumon, 1998; Slutsky, 1999). Our 
previous studies aimed at evaluating the mechanisms that may underlie the pathogenesis of 
VILI and MOF (figure 5). To summarize, we demonstrated that both LVT and HVT-
ventilation increased pulmonary cytokine, chemokine and adhesion molecule expression 
accompanied by significant granulocyte infiltration (Hegeman et al, 2011b). We observed 
that 5 hours of either LVT or HVT-ventilation primarily induced caspase-independent 
pathways of cell death (figure 3). In addition, our findings strongly suggest that changes in 
the Ang-Tie2 system, together with elevated VEGF expression, are involved in the 
development of VILI  (figure 4) (Hegeman et al, 2010). An intriguing clinical observation is 
that most critically ill ALI/ARDS patients do not succumb to acute lung failure but rather to 
progressive non-pulmonary organ dysfunction, so-called MOF (Ferring & Vincent, 1997; 
Montgomery et al, 1985; Valta et al, 1999). In this respect, we showed that mechanical 
ventilation with high pressures increased the pro-inflammatory state of the lung but also of 
the liver and kidney (figure 1) (Hegeman et al, 2009). Moreover, we observed that HVT-
ventilation impairs functioning of peripheral lymphocytes (figure 2). Together, these data 
indicate that ventilator-induced alveolar (over)stretch may play a significant role in the 
pathogenesis of both VILI and MOF.  
Based on the hypothesis that a ventilator-induced inflammatory response may precede lung 
injury, we evaluated the effects of different anti-inflammatory intervention strategies on 
various aspects considered to be important in the development of VILI. One of the most 
potent drugs to downregulate inflammatory responses are glucocorticoids (Brower et al, 
2001; Luce, 2002). Despite the successful inhibitory effect on lung inflammation, we 
observed that glucocorticoid therapy did not prevent the elevation in BALf total protein 
levels, the increase in pulmonary wet-to-dry ratio and reduction of PaO2/FiO2 ratio during 
mechanical ventilation (Hegeman et al, 2011b). Similarly, the vessel protective factor Ang-1 
did not protect ventilated mice against these more crude aspects of VILI even though 
granulocyte infiltration, inflammatory mediator and VEGF expression were markedly 
diminished (Hegeman et al, 2010). Thus, prevention of inflammation does not preclude loss 
of pulmonary function implying that lung inflammation and injury are two independent 
components of VILI.  
In view of these most recent findings, we propose that anti-inflammatory therapy may not 
prevent the aspects of VILI driven by mechanosensitive alterations in barrier properties, like 
vascular leakage and impaired gas exchange, but will only regulate pulmonary 
inflammation. Therefore, future therapeutic intervention strategies in the ventilated, 
critically ill patient should aim at attacking the ventilator-induced impairment of alveolar-
capillary barrier function. As Rho GTPases have been described to be important in the 
mechanosensitive regulation of endothelial barrier function (Birukov, 2009), ROCK or GEF-
H1 inhibitors might be an attractive target to prevent the detrimental effects induced by the 
alveolar (over)stretch associated with mechanical ventilation. In addition, the attenuation of 
caspase-independent cell death – via calpain inhibitors or RIP-kinase inhibitors such as 
necrostatin – might also be a preventive strategy in maintaining alveolar-capillary barrier 
function. Moreover, restoring function of damaged tissue by autologous stem cell 
transplantation could become a beneficial approach to treat the critically ill patient as well. 
Nonetheless, preventing prolonged exposure to mechanical stretch by reducing tidal 
volumes remains of utmost importance. 
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Fig. 5. Possible mechanisms that may underlie the pathogenesis of ventilator-induced lung 
injury (VILI) and multiple-organ failure (MOF).  
Part of illustration adapted with permission of H.A.E. Vreugdenhil (Thesis “Mechanical 
ventilation and immune function” by H.A.E. Vreugdenhil, 2003). Although life-saving, 
mechanical ventilation may cause harm by itself. Our previous studies investigated the 
mechanisms that may underlie the pathogenesis of VILI and MOF in healthy mice. We 
showed that mechanical ventilation provokes endothelial activation (including changes in 
the angiopoietin (Ang)-Tie2 system), inflammation and cell death (primarily via activation 
of the caspase-independent route) in pulmonary tissue. Besides these local effects of 
mechanical ventilation, we also demonstrated enhanced endothelial activation and 
inflammation in hepatic and renal tissue (enhanced pro-inflammatory milieu of distal 
organs). In addition, we observed reduced mitogen-induced splenocyte proliferation after 
mechanical ventilation with high tidal volumes (suppressed peripheral lymphocyte 
functioning). Alv = alveolar epithelial cell; Mϕ = macrophage. 
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